Abhijit Saha

Abhijit Saha

Auto-generated profile, based on publicly available information

Abhijit Saha

UGC-DAE Consortium for Scientific Research, Kolkata, India

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2017 in Langmuir
Verified
Journal Article
Closed access
SMSusmita Maiti
Susmita Maiti
SKSomashree Kundu
Somashree Kundu
CRChandra Nath Roy
Chandra Nath Roy
TDTushar Kanti Das
Tushar Kanti Das
ASAbhijit Saha
Abhijit Saha

1 November 2020 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
CDChanchal Das
Chanchal Das
SPSUBHA SANKAR PAUL
SUBHA SANKAR PAUL
ASArighna Saha
Arighna Saha
Tejinder SinghTejinder Singh
Tejinder Singh
ASAbhijit Saha
Abhijit Saha
Goutam BiswasGoutam Biswas
Goutam Biswas
Since the identification of the first human coronavirus in the 1960s, a total of six coronaviruses that are known to affect humans have been identified: 229E, OC43, severe acute respiratory syndrome coronavirus (SARS-CoV), NL63, HKU1, and Middle East respiratory syndrome coronavirus (MERS-CoV). Presently, the human world is affected by a novel version of the coronavirus family known as SARS-CoV-2, which has an extremely high contagion rate. Although the infection fatality rate (IFR) of this rapidly spreading virus is not high (ranging from 0.00% to 1.54% across 51 different locations), the increasing number of infections and deaths has created a worldwide pandemic situation. To provide therapy to severely infected patients, instant therapeutic support is urgently needed and the repurposing of already approved drugs is presently in progress. In this regard, the development of nanoparticles as effective transporters for therapeutic drugs or as alternative medicines is highly encouraged and currently needed. The size range of the viruses is within 60– 140 nm, which is slightly larger than the diameters of nanoparticles, making nanomaterials efficacious tools with antiviral properties. Silver-based nanomaterials (AgNMs) demonstrate antimicrobial and disinfectant effects mostly by generating reactive oxygen species (ROS) and are presently considered as a versatile tool for the treatment of COVID-19 patients. Other metal-based nanoparticles have been primarily reported as delivery agents or surface modifying agents, vaccine adjuvant against coronavirus. The present review summarizes and discusses the possible effectiveness of various surface-modified AgNMs against animal coronaviruses and presents a concept for AgNM-based therapeutic treatment of SARS-CoV-2 in the near future.

9 November 2011 in Journal of Materials Chemistry
Verified
Journal Article
Closed access
PDF file
DGDebasmita Ghosh
Debasmita Ghosh
Somrita MondalSomrita Mondal
Somrita Mondal
SGSrabanti Ghosh
Srabanti Ghosh
ASAbhijit Saha
Abhijit Saha
The present investigation demonstrates the role of protein conformation in synthesizing nanoparticles (NPs) through biomimetic route. Highly water-soluble and biocompatible CdS and CdSe nanoparticles in bovine serum albumin (BSA) matrix have been synthesized using a simple and controllable method at room temperature. Fourier transform infrared (FTIR) data are used to envisage the binding of the semiconducting particles with amide and OH groups of the protein molecule. Optical absorption and emission spectra confirm that particles formed lie within the size quantization regime. Circular dichroism spectroscopy reveals that BSA adopts different conformations at different pH which in turn controls the particle size. Further, addition of sodium borohydride (NaBH4) in BSA solution results in breakage of disulfide bonds generating increased number of thiolate groups which provide better stabilization and increased passivation of electronic defects on particle surface. In the process, better quality semiconductor NPs with higher quantum yield are produced. Thus, by modulating the protein conformation, the size and quality of the nanoparticles can be controlled.

12 July 2009 in Journal of Fluorescence
Verified
Journal Article
Closed access
PDF file
SGSrabanti Ghosh
Srabanti Ghosh
APAmiya Priyam
Amiya Priyam
SBSubhash C. Bhattacharya
Subhash C. Bhattacharya
ASAbhijit Saha
Abhijit Saha

15 April 2010 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
SGSrabanti Ghosh
Srabanti Ghosh
SBS. C. Bhattacharya
S. C. Bhattacharya
ASAbhijit Saha
Abhijit Saha

6 February 2009 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
APA. Priyam
A. Priyam
SGS. Ghosh
S. Ghosh
SBS.C. Bhattacharya
S.C. Bhattacharya
ASA. Saha
A. Saha